September 7, 2026 Korea’s EuBiologics Received WHO Prequalification for its Typhoid Conjugate Vaccine Members' achievements Vaccines & immunization WHO PQ
August 21, 2026 DCVMN at India Vaccine Leaders Conclave: Advancing Vaccine Innovation, AI and Supply Resilience CEO DCVMN Advocacy Vaccines & immunization
May 4, 2026 Serum Institute of India Entered Licence Agreement with the University of Oxford to Advance the Development of a Next-Generation Multi-Stage Malaria Vaccine Malaria Members' achievements Vaccines & immunization
April 3, 2026 DCVMN at the World Vaccine Congress 2026: Advancing AI, Sustainability, and Global Vaccine Equity DCVMN Advocacy DCVMN Board Vaccines & immunization
November 26, 2025 DCVMN at the Pharma Connect Congress 2025 DCVMN Advocacy developingcountries Vaccines & immunization
October 29, 2025 Global Vaccine Safety Network Launched — INNOVATE — Joint Project of CEPI, DCVMN and INCLEN DCVMN achievements Pharmacovigilance Vaccines & immunization WeConnectToProtect
October 13, 2025 DCVMN at the World Health Summit on Vaccine Manufacturing in Africa Africa DCVMN Advocacy developingcountries Vaccines & immunization
August 26, 2025 Regulatory Approval for CNBG’s Rotavirus Vaccine, Rotasiro® by NMPA Members' achievements Vaccines & immunization
June 27, 2025 DCVMN at the Global Summit: Health and Prosperity through Immunisation CEO DCVMN Advocacy Vaccines & immunization WeConnectToProtect
June 4, 2025 Regulatory Approval for Innovax’s HPV vaccine, Cecolin®9 from NMPA Members' achievements Vaccines & immunization
